Thursday, October 23, 2025

4:30 PM - 5:15 PM

---

Details

Cell and gene therapies like CAR T have redefined what’s possible in treating cancer and rare diseases—but with costs often exceeding US$300,000, access remains limited. This panel explores how the next generation of personalised treatments can be made more accessible and scalable without compromising precision. Featuring innovations such as regionally manufactured cell therapies, photodynamic therapy (PDT), and targeted small molecules, the discussion will spotlight emerging models that reduce complexity and cost. With insights from biotech leaders and investors, the panel will examine how Asia-Pacific innovators are reshaping the global landscape for affordable, personalised care. From platform technologies to funding strategies and regulatory pathways, we’ll explore what it takes to bring cell and gene therapies to more patients, more affordably.

---

Speaker